HealthEquity (NASDAQ:HQY) Updates FY 2027 Earnings Guidance

HealthEquity (NASDAQ:HQY) updated its FY 2027 earnings guidance on Thursday. The company provided earnings per share guidance of 2.880-2.950 for the period, compared to the consensus earnings per share estimate of 4.470. The company issued revenue guidance of -.

HealthEquity Price Performance

HealthEquity stock traded up $3.96 during trading hours on Thursday, hitting $90.52. 1,239,628 shares of the stock were exchanged, compared to its average volume of 995,669. The company has a debt-to-equity ratio of 0.45, a quick ratio of 3.27 and a current ratio of 3.27. The stock has a market capitalization of $7.59 billion, a P/E ratio of 36.80, a P/E/G ratio of 1.59 and a beta of 0.19. HealthEquity has a 12 month low of $72.76 and a 12 month high of $116.65. The business’s 50-day moving average is $83.05 and its two-hundred day moving average is $86.78.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.13. The firm had revenue of $354.64 million for the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity had a net margin of 16.39% and a return on equity of 13.86%. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities research analysts expect that HealthEquity will post 3.84 EPS for the current fiscal year.

Analysts Set New Price Targets

HQY has been the topic of several research analyst reports. BTIG Research decreased their price objective on shares of HealthEquity from $130.00 to $110.00 and set a “buy” rating on the stock in a research note on Tuesday, February 17th. Wall Street Zen cut shares of HealthEquity from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a research note on Thursday, March 19th. Barrington Research reaffirmed an “outperform” rating and set a $110.00 price objective on shares of HealthEquity in a research note on Friday, May 22nd. Finally, Jefferies Financial Group set a $108.00 price objective on shares of HealthEquity in a research note on Thursday, February 19th. One research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, HealthEquity currently has an average rating of “Moderate Buy” and a consensus price target of $111.79.

Institutional Trading of HealthEquity

Several hedge funds have recently modified their holdings of HQY. Acumen Wealth Advisors LLC bought a new stake in shares of HealthEquity during the fourth quarter valued at approximately $27,000. Aster Capital Management DIFC Ltd bought a new stake in shares of HealthEquity during the fourth quarter valued at approximately $28,000. Caitong International Asset Management Co. Ltd grew its stake in shares of HealthEquity by 1,723.5% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after purchasing an additional 293 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in shares of HealthEquity by 190.4% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 604 shares of the company’s stock valued at $55,000 after purchasing an additional 396 shares during the last quarter. Finally, Larson Financial Group LLC grew its stake in shares of HealthEquity by 24.4% during the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after purchasing an additional 123 shares during the last quarter. 99.55% of the stock is owned by institutional investors.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.